Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Candela Corp.

This article was originally published in The Gray Sheet

Executive Summary

Aesthetic and cosmetic laser system maker's secondary offering of 2.43 mil. shares of common stock at $14 per share is outlined in a prospectus filed July 23 with the Securities and Exchange Commission. Of the shares being offered, approximately 1.5 mil. are being sold by the company and about 930,000 are being offered by selling shareholders. Estimated proceeds to Candela of approximately $19.3 mil. will be used for general corporate purposes, including working capital. The Wayland, Massachusetts firm's offering is being managed by Needham & Company and Tucker Anthony Cleary Gull
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT012104

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel